Related Content
- Big Molecule WatchFebruary 14, 2025
Dr. Reddy’s Secures License from Henlius to Market Daratumumab Biosimilar in the U.S. and Europe
- Big Molecule WatchFebruary 11, 2025
Regulatory and Commercial Updates on Bio-Thera’s BAT2506 (golimumab)
- Big Molecule WatchFebruary 10, 2025
HyClone Seeks to Quash Amgen’s Subpoena Issued in Denosumab BPCIA Litigation Against Fresenius
- Big Molecule WatchFebruary 7, 2025
EU Biosimilar Regulatory and Launch Updates
- Big Molecule WatchFebruary 6, 2025
BioNTech Acquires Biotheus To Boost Oncology Strategy
- Big Molecule WatchFebruary 6, 2025
Federal Circuit Affirms Injunction Against Samsung and Formycon in Aflibercept BPCIA Litigation
- Big Molecule WatchFebruary 6, 2025
FDA Accepts BLA for Shanghai Henlius Biotech’s HLX11, a Pertuzumab Biosimilar
- Big Molecule WatchFebruary 4, 2025
FDA Publishes Its First Draft Guidance On Use of Artificial Intelligence in the Development of Drugs and Biological Products
- Awards and RankingsSeptember 9, 2024
Goodwin Named Venture Capital Firm of the Year, Hatch-Waxman Litigation Firm of the Year and Life Cycle Firm of the Year at the 2024 LMG Life Sciences Americas Awards
- Awards and RankingsSeptember 25, 2023
Goodwin Named an LMG Life Sciences Life Cycle Firm for the Twelfth Consecutive Year
- Awards and RankingsOctober 4, 2022
LMG Recognizes Goodwin Lawyers and Practices for Excellence in Life Sciences
- Press ReleaseNovember 17, 2021
Goodwin Releases Update to its Comprehensive Guide to Biosimilars Litigation and Regulation in the U.S.
- Awards and RankingsOctober 26, 2021
Goodwin Named an LMG Life Sciences Life Cycle Firm for the Tenth Consecutive Year
- Press ReleaseJune 28, 2021
Goodwin Adds Life Sciences and Healthcare Litigation Partner William Jackson
- EventsDecember 5, 2020
China's Patent Linkage System: Can Strategies that Work in the U.S. System Be Applied to China?
- Awards and RankingsOctober 5, 2020
Goodwin Named An LMG Life Sciences Life Cycle Firm For The Ninth Consecutive Year